Clinical Trial Update: Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III) [Phase 3]

View source ↗

Summary

Phase III clinical trial update for a measles-rubella combined vaccine (MRVAC) produced by POLYVAC; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Rubella

Drugs mentioned

• Measles - Rubella Combined Vaccine (MRVAC) produced by POLYVAC (Measles and rubella combined vaccine)

Snippet

Sponsor: Center for Research and Production of Vaccines and Biologicals, Vietnam | Conditions: Signs and Symptoms | Phase 3 | Status: COMPLETED